Richard A. Young

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard A. Young

Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
2,667
Estimated value
$4,470
Report date
16 Sep 2024
Price
$1.68
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omega Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
Report date
20 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
6,000
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Camp4 Therapeutics Corp

Security class
Series A Prime Preferred Stock
Shares / value
0
Estimated value
Report date
15 Oct 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard A. Young

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .